Concepedia

Author

Yuequan Shi

Peking Union Medical College Hospital

Also Known As

Y F Shi, Y. Shi, Yue-Quan Shi, Yuequan Shi, Yuyi Shi

47

Publications

459

Citations

14

H-Index

17

Concepts

All Affiliations

Peking Union Medical College HospitalChinese Academy of Medical Sciences & Peking Union Medical CollegeChina Medical UniversityZhejiang UniversityHospital Universitario Puerta de Hierro Majadahonda
YS

About

Yuequan Shi is an author at Peking Union Medical College Hospital specializing in immunology, medicine, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

27

2

Immunology

2

2

27

3

Pathology

2

2

27

4

Autoimmune Disease

1

1

17

5

Autoimmunity

1

1

17

Yuequan Shi

×

13

Publications

313

Citations

11

H-Index

YearCitations

Different signaling pathways involved in the anti-inflammatory effects of unfractionated heparin on lipopolysaccharide-stimulated human endothelial cells

Li Xu, Lu Li, Yuequan Shi,

Journal of Inflammation

2020

45

Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments

Yuequan Shi, Xiaoyan Liu, Jia Liu,

Translational Lung Cancer Research

2021

38

Immune checkpoint inhibitor‐related adverse events in lung cancer: Real‐world incidence and management practices of 1905 patients in <scp>China</scp>

Yuequan Shi, Jian Fang, Chengzhi Zhou,

Thoracic Cancer

2021

37

Risk factors for acute respiratory distress syndrome in sepsis patients: a retrospective study from a tertiary hospital in China

Yuequan Shi, Liang Wang, Sihan Yu,

BMC Pulmonary Medicine

2022

35

Circulating cytokines associated with clinical outcomes in advanced non‐small cell lung cancer patients who received chemoimmunotherapy

Yuequan Shi, Xiaoyan Liu, Juan Du,

Thoracic Cancer

2021

33

Circulating tumor cells <scp>PD‐L1</scp> expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non‐small‐cell lung cancer

Qing Zhou, Xiangning Liu, Ji Li,

Thoracic Cancer

2023

24

Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study

Dongming Zhang, Xiaoyan Liu, Fangfang Shen,

Translational Lung Cancer Research

2023

18

Safety and efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients with preexisting antinuclear antibodies: a retrospective cohort study

Dongming Zhang, Yuequan Shi, Xiaoyan Liu,

Translational Lung Cancer Research

2022

17

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus

Jia Liu, Yuequan Shi, Xiaoyan Liu,

Translational Oncology

2022

17

Comparison of Chemotherapy Plus Pembrolizumab vs. Chemotherapy Alone in EGFR-Mutant Non–small-Cell Lung Cancer Patients

Minjiang Chen, Yan Xu, Jing Zhao,

Clinical Lung Cancer

2022

15

Page 1